C180SE High Heat Sterilization CO2 Incubator Powers CNPG Pharmaceutical’s Antibiotic Advancements
Our C180SE High Heat Sterilization CO2 Incubator is catalyzing revolutionary strides in antibiotic development at a leading CNPG Pharmaceutical subsidiary. This state-of-the-art incubator is the linchpin behind groundbreaking discoveries in the quest for superior antibiotic raw material drugs.
Tasked with creating an optimal environment for critical cell culture experiments, the C180SE ensures the reliability and integrity of cell cultures essential for antibiotic compound development. In collaboration with CNPG’s pharmaceutical arm, we’re propelling innovation, pushing the frontiers of healthcare solutions, and redefining possibilities in the pharmaceutical landscape.
Post time: Mar-10-2021